Eplerenone in chronic renal disease: the EVALUATE trial
- PMID: 20448638
- DOI: 10.1038/hr.2010.71
Eplerenone in chronic renal disease: the EVALUATE trial
Comment on
-
Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria.Hypertens Res. 2010 Jun;33(6):616-21. doi: 10.1038/hr.2010.46. Epub 2010 Apr 9. Hypertens Res. 2010. PMID: 20379190 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical